CLANDESTINE DRUG PRODUCTION LABORATORIES IN SERBIA

Božidar Otašević, Dag Kolarević, Ivana Radovanović

DOI Number
https://doi.org/10.22190/TEME191026067O
First page
1125
Last page
1140

Abstract


The problem of the existence of illegal drug production laboratories in the world was recorded as early as in the mid-twentieth century. At the beginning of the twentieth century, this global problem affected Serbia, too, when the first clandestine drug production laboratories, whose production capacities exceeded the demands of the Serbian drug market, were uncovered. The aim of this paper is to determine the characteristics of illegal laboratories for the production of narcotics in the Republic of Serbia and how widespread they are. On the basis of the data provided by the Department of Analytics at the Ministry of the Interior of the Republic of Serbia, data relating to all illegal laboratories uncovered in Serbia (excluding Kosovo and Metohija) in the period from 2003 to 2019 was used. An exploratory research has been conducted analyzing 147 uncovered laboratories in which 245 illegal manufacturers were imprisoned. The production of marijuana took place in 92.5% of the laboratories, in 6.8% of cases synthetic drugs were produced, while hallucinogenic mushrooms were grown in one laboratory. A cartographic representation of how widespread the laboratories are and their basic characteristics in terms of location, production capacity and the type of installed equipment has also been provided.


Keywords

drugs, illicit production, laboratory, marijuana, synthetic drugs.

Full Text:

PDF

References


Ahmad, F.L, Chang, K.H, Wan Nur Syuhaila, M.D, Maimonah, S., Raihanah, H. & Kunalan, V. (2014). Clandestine Drug Laboratory: Emergence, Types, Factors and Problems. Health and the Environment Journal. 5(2):11-27.

Australian Criminal Intelligence Commission - Clandestine laboratories and precursors The Illicit Drug Data Report - IDDR 2015–16, accessed https://www.acic.gov.au/files/clandestine-laboratories-and-precursors-iddr-2015-16-56219-kb, 25.09.2019.

Christian, D.R., (2004). Forensic investigation of clandestine laboratories. Boca Raton: CRC Press.

Diplock, J., Kirkland, S., Malm, A. & Plecas, D., (2005). Clandestine drug laboratories in British Columbia, Centre for Criminal Justice Research (CCJR), University College of the Fraser Valley.

European Monitoring Centre for Drugs and Drug Addiction (2009). Serbia Country Overview 2009.

EnHealth (2017). EnHealth Guidance on: Clandestine Drug Laboratories and Public Health Risks accessed (2017) https://www1.health.gov.au/internet/main/publishing.nsf/Content/A12B57E41EC9F326CA257BF0001F9E7D/$File/Guidance-Clandestine-Drug-Laboratories-Public-Health.pdf , 25.09.2019.

Hadžić, P. & Zorić, V., (2009). Ilegalne laboratorije za proizvodnju droge – policijska i kriminalistička obrada. [Illegal drug production laboratories - police and criminal processing]. Nauka, bezbednost, policija, 14(1),161–175.

Jugović, A., (2004). Rizična ponašanja omladine u Srbiji. [Risky behaviour of youth in Serbia]. U S. Mihailović (ur.), Mladi zagubljeni u tranziciji, str. (177–203). Beograd: Centar za proučavanje alternative.

Kostić, M. (2000). Proizvodnja i trgovina drogom unutar Evropske unije. [Drug production and drug trafficking within the European Union]. Bezbednost, 41(1), 121–132.

Office of National Drug Control Policy (2006), Methamphetamine and Related Crime: The Impacts of Methamphetamine Abuse, Northwest High IntensityDrug Trafficking Area Program, accessed http://www.npaihb.org/images/epicenter_docs/Meth/docs/Methandrelatedcrime.pdf 25.09.20019.

Otašević, B., Atanasov, S., (2018). Sources of danger at the site of discovery of secret labs for drugs production. U S. Mijalković(ur). Thematic conference proceedings of international significance, Academy of criminalistic and police studies, „Archibald Reiss Days“ Belgrade, volume II, p. 330-337.

Otašević, B., (2018). Procedure na mestu otkrivanja tajnih laboratorija za proizvodnju droga. [Procedures at the Site of Discovery of Clandestine Drug Production Laboratories]. Bezbjednost, policija i građani, Banja Luka, 14(1): 3–20. doi 10.7251 BPG 18010030.

Otašević, B., Atanasov, S., Dostić, S., (2018). Sources of material evidence in the procedure fpr detection of clandestine labaratories for the manufacture of syntetic drugs: U M. Gurovski (ur.) 9th international scientific konference, Security system reforms as a precondition for euro – atlantic integrations, Skopje, vol. III, p. 78-88.

Radovanović, I., Lajić, O., (2016). Zloupotreba droge kao oblik kriminala maloletnika – problemi istraživanja, fenomenološke karakteristike i odnos sa nekim poremećajima ponašanja. [Drug Abuse as a Form of Juvenile Crime - Research Problems, Phenomenological Characteristics, and Relationship with Certain Behavioural Disorders]. U: Kolarić, D. (ur.) Tematski zbornik radova – Kriminalitet u Srbiji i instrumenti državne reakcije, p. 343–376.

Risimović, R., (2018). Da li je opravdana legalizacija medicinske i rekreativne upotrebe kanabisa? [Is the legalization of medical and recreational use of cannabis justified?] NBP-Žurnal za kriminalistiku i parvo, 23(3): 251–265. Doi 10.5937/nabepo23-18781.

Risimović, R., Bošković, A., (2018). Neovlašćeno stavljanje u promet opojnih droga zloupotrebom interneta. Unlawful Circulation of Narcotics through Internet Abuse. Bezbednost, 60(3): 26–42. doi.105937/bezbednost1803026R.

Scott, M.S. (2002). Clandestine drug labs. U.S. Department of Justice, Office of Community Oriented Policing Service.

(2017). Strateška procena javne bezbednosti [Public Security Strategic Assessment], Ministarstvo unutrašnjih poslova Republike Srbije, Beograd.

Scott, M.S., Dedel, K., (2006). Clandestine methamphetamine labs. 2nd edition. U.S. Department of Justice, Office of Community Oriented Policing Service.

Stanković, M., (2008). Droga i kriminal. [Drugs and Crime]. Beograd:Simbol.

The Australian Government (2011). Clandestine Drug Laboratory Remediation Guidelines.

UNODC, (2010). World Drug Report 2010. United Nation of Drugs and Crime, Vienna: United Nations Publication.

UNODC, (2012). World Drug Report 2012. United Nations publication, Sales No. E.12.XI.1

UNODC, (2016). World Drug Report 2016. United Nations publication, Sales No. E.16.XI.7).

Vernon, A., (2009). Clandestine Drug Labs Serious Dangers to Responders, decembar 15, dostupno na: www.firehouse.com/safety-health/article/10470318/clandestine-drug-labs-pose-serious-dangers-toresponders, accessed 15.01.2018.

Chiu, Y. N., Leclerc, B., & Townsley, M. (2011). Crime script analysis of drug manufacturing in clandestine laboratories: Implications for prevention. The British Journal of Criminology, 51(2), 355-374. doi.org/10.1093/bjc/azr005.

Vandrey, R., Herrmann, E. S., Mitchell, J. M., Bigelow, G. E., Flegel, R., LoDico, C., & Cone, E. J. (2017). Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes. Journal of analytical toxicology, 41(2), 83-99. doi. org/10.1093/jat/bgx012.

Wright J. (2015). NSW Remediation Guidelines for Clandestine Drug Laboratories and Hydroponic Drug Plantation, A Report to Health Protection NSW.




DOI: https://doi.org/10.22190/TEME191026067O

Refbacks

  • There are currently no refbacks.


© University of Niš, Serbia
Creative Commons licence CC BY-NC-ND
Print ISSN: 0353-7919
Online ISSN: 1820-7804